NovoCure Ltd.

251 articles with NovoCure Ltd.

• NovoCure Ltd. To Present New Pre-Clinical Data On NovoTTF™ Therapy At American Association for Cancer Research Annual Meeting 2014

  4/3/2014

• NovoCure Ltd. Enrolls First Patient In Pilot Clinical Trial Of Novottf™ Therapy Plus Gemcitabine For First-Line Treatment Of Advanced Pancreatic Adenocarcinoma

  1/24/2014

• NovoCure Ltd. Release: Data Published In Pancreatology Demonstrates Activity Of NovoTTF™ Therapy In Preclinical Models Of Pancreatic Cancer, Alone And In Combination With Chemotherapy

  1/7/2014

• NovoCure Ltd. Enrolls First Patients In A Randomized Trial Of Novottf&#0153 Therapy For Patients With Brain Metastases From Non-Small Cell Lung Cancer

  11/19/2013

• NovoCure Ltd. To Present Fifteen Abstracts Describing Latest Aspects Of NovoTTF™ Therapy At The 4th Quadrennial Meeting Of The World Federation Of Neuro-Oncology (WFNO)

  11/18/2013

• NovoCure Ltd. Announces FDA Approval of the NovoTAL™ (Transducer Array Layout) System

  11/5/2013

• NovoCure Ltd. Release: Results of First Multi-Center Trial of NovoTTF&#0153 Therapy in Combination With Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) Published in Lung Cancer

  9/4/2013

• NovoCure Ltd. to Present NovoTTF™ Therapy Data at the 2013 Annual Scientific Meeting of the American Society of Clinical Oncology

  5/31/2013

• NovoCure Ltd. Release: Clinical Trial for Newly Diagnosed Glioblastoma Opened in Korea

  5/7/2013

• NovoCure Ltd. Presents Preclinical Data at the American Association for Cancer Research

  4/10/2013

• NovoCure Ltd. Release: NCCN Guidelines&#0174 Recommend NovoTTF&#0153 Therapy as a Standard Treatment Option for CNS Cancers

  1/22/2013

• NovoCure Ltd. Appoints Four New Independent Members to its Board of Directors

  1/8/2013

• NovoCure Ltd. Release: New Data on NovoTTF™ Therapy to be Presented at the 2012 SNO Meeting

  11/14/2012

• NovoCure Ltd. Release: Galien Foundation Selects NovoTTF&#0153-100A System as a Finalist for the Prix Galien USA Award

  8/10/2012

• NovoCure Ltd. to Present NovoTTF(TM) Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology

  5/30/2012

• NovoCure Ltd. Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy

  5/25/2012

• Study Results of NovoCure Ltd.'s NovoTTF(TM) Pivotal Phase 3 Trial Published in European Journal of Cancer

  5/22/2012

• NovoCure Ltd. Announces Launch of Recurrent Glioblastoma Product Website

  5/15/2012

• NovoCure Ltd. Announces Appointment of Wilco Groenhuysen as Chief Financial Officer

  1/5/2012

• NovoCure Ltd. Adds Three Senior Oncology Executives to its Global Management Team

  12/19/2011